Frederick A. Zeiler
University of Cambridge, Manitoba Health, University of Manitoba
Papers
5
Total Citations
201
H-Index
5
About
Frederick A. Zeiler is a leading figure in neurocritical care and traumatic brain injury (TBI) research, pioneering the shift from invasive to entirely non-invasive cerebrovascular monitoring. His work centers on developing and validating novel methods for assessing cerebrovascular reactivity—the brain's ability to regulate blood flow—without the need for invasive brain monitors. Dr. Zeiler’s major contributions include the application of robotic transcranial Doppler (TCD) technology for extended, uninterrupted recordings in moderate/severe TBI patients, a breakthrough that overcomes the traditional labor-intensive limitations of TCD. He has also introduced and validated the non-invasive pressure reactivity index (PRx) using Doppler systolic flow parameters, enabling continuous, bedside assessment of autoregulation. His highly cited works, such as his 2018 paper on robotic TCD (57 citations) and his 2020 paper on non-invasive reactivity assessment (46 citations), have collectively shaped the field. By demonstrating the feasibility of deriving optimal cerebral perfusion pressure (CPPopt) non-invasively, Dr. Zeiler has paved the way for individualized, data-driven TBI management in both acute and outpatient settings, significantly advancing patient safety and monitoring capabilities.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5